These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 9427708)
1. Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients. Polgár J; Eichler P; Greinacher A; Clemetson KJ Blood; 1998 Jan; 91(2):549-54. PubMed ID: 9427708 [TBL] [Abstract][Full Text] [Related]
2. Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications. Haas S; Walenga JM; Jeske WP; Fareed J Semin Thromb Hemost; 1999; 25 Suppl 1():67-75. PubMed ID: 10357155 [TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217 [TBL] [Abstract][Full Text] [Related]
4. Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia. Mousa SA; Ahmad S Am J Hematol; 2007 Apr; 82(4):276-82. PubMed ID: 17039513 [TBL] [Abstract][Full Text] [Related]
5. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors. Jin J; Quinton TM; Zhang J; Rittenhouse SE; Kunapuli SP Blood; 2002 Jan; 99(1):193-8. PubMed ID: 11756171 [TBL] [Abstract][Full Text] [Related]
6. Effect of SR121566A, a potent GP IIb-IIIa antagonist, on the HIT serum/heparin-induced platelet mediated activation of human endothelial cells. Herbert JM; Savi P; Jeske WP; Walenga JM Thromb Haemost; 1998 Aug; 80(2):326-31. PubMed ID: 9716161 [TBL] [Abstract][Full Text] [Related]
7. Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets. Jeske WP; Walenga JM; Szatkowski E; Ero M; Herbert JM; Haas S; Bakhos M Thromb Res; 1997 Nov; 88(3):271-81. PubMed ID: 9526947 [TBL] [Abstract][Full Text] [Related]
8. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP. Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T Biochem Pharmacol; 2000 Jun; 59(11):1345-55. PubMed ID: 10751543 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors. Paul BZ; Jin J; Kunapuli SP J Biol Chem; 1999 Oct; 274(41):29108-14. PubMed ID: 10506165 [TBL] [Abstract][Full Text] [Related]
10. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine. Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet action of R-99224, an active metabolite of a novel thienopyridine-type G(i)-linked P2T antagonist, CS-747. Sugidachi A; Asai F; Yoneda K; Iwamura R; Ogawa T; Otsuguro K; Koike H Br J Pharmacol; 2001 Jan; 132(1):47-54. PubMed ID: 11156560 [TBL] [Abstract][Full Text] [Related]
12. FcgammaRIIA requires a Gi-dependent pathway for an efficient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation. Gratacap MP; Hérault JP; Viala C; Ragab A; Savi P; Herbert JM; Chap H; Plantavid M; Payrastre B Blood; 2000 Nov; 96(10):3439-46. PubMed ID: 11071639 [TBL] [Abstract][Full Text] [Related]
13. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin. Storey RF; May JA; Heptinstall S Thromb Res; 2005; 115(4):301-7. PubMed ID: 15668190 [TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia: effect of heparin platelet antibody on platelets. Chong BH; Grace CS; Rozenberg MC Br J Haematol; 1981 Dec; 49(4):531-40. PubMed ID: 7317283 [TBL] [Abstract][Full Text] [Related]
15. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation. Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429 [TBL] [Abstract][Full Text] [Related]
16. FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors. Humphries RG; Tomlinson W; Ingall AH; Cage PA; Leff P Br J Pharmacol; 1994 Nov; 113(3):1057-63. PubMed ID: 7858849 [TBL] [Abstract][Full Text] [Related]
17. Heparin-induced thrombocytopenia: further studies of the effects of heparin-dependent antibodies on platelets. Chong BH; Castaldi PA Br J Haematol; 1986 Oct; 64(2):347-54. PubMed ID: 3778828 [TBL] [Abstract][Full Text] [Related]
18. A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation. Soslau G; Youngprapakorn D Biochim Biophys Acta; 1997 Feb; 1355(2):131-40. PubMed ID: 9042333 [TBL] [Abstract][Full Text] [Related]
19. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors. Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355 [TBL] [Abstract][Full Text] [Related]
20. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy. Rozalski M; Nocun M; Watala C Acta Biochim Pol; 2005; 52(2):411-5. PubMed ID: 15912207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]